CorVel Q4 revenue rises on strong CERIS demand

CorVel

20/05/2026 11:23

Overview

US healthcare cost management firm's fiscal Q4 revenue grew 7% yr/yr, EPS up 20%

Company repurchased $20.1 mln of common stock during the quarter

CERIS division benefited from industry shift to proactive payment accuracy and cost management

Outlook

Company highlights strong demand for CERIS platform and increased revenue visibility from new contracts

CorVel says ongoing investment in AI and automation expected to support margins and scalability

Company expects technology and automation to improve operational efficiency and claim outcomes

Result Drivers

CERIS DEMAND - Co said CERIS division saw strong demand due to healthcare industry's shift toward proactive payment accuracy and cost management

LARGE PAYER SALES - Co said multiple large payer sales with enterprise-scale implementations increased revenue visibility as they are deployed and scaled

TECHNOLOGY INVESTMENT - Co said ongoing investments in AI, automation, and technology-enabled models improved operational efficiency and claim outcomes

Company press release: ID:nGNX5VLWtZ

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q4 Revenue
$248.5 mln
Q4 EPS
$0.61


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)